BG104761A - Benzofurylpyrone derivatives - Google Patents
Benzofurylpyrone derivativesInfo
- Publication number
- BG104761A BG104761A BG104761A BG10476100A BG104761A BG 104761 A BG104761 A BG 104761A BG 104761 A BG104761 A BG 104761A BG 10476100 A BG10476100 A BG 10476100A BG 104761 A BG104761 A BG 104761A
- Authority
- BG
- Bulgaria
- Prior art keywords
- represents hydrogen
- benzofurylpyrone
- derivatives
- remedies
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Farming Of Fish And Shellfish (AREA)
- Furan Compounds (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6135698 | 1998-03-12 | ||
| PCT/JP1999/001225 WO1999046262A1 (fr) | 1998-03-12 | 1999-03-12 | Derives de benzofurylpyrone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104761A true BG104761A (en) | 2001-08-31 |
Family
ID=13168805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104761A BG104761A (en) | 1998-03-12 | 2000-09-12 | Benzofurylpyrone derivatives |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6589984B1 (xx) |
| EP (1) | EP1063235B1 (xx) |
| JP (1) | JP3922884B2 (xx) |
| KR (1) | KR100595332B1 (xx) |
| CN (1) | CN1170827C (xx) |
| AT (1) | ATE266659T1 (xx) |
| AU (1) | AU756965B2 (xx) |
| BG (1) | BG104761A (xx) |
| BR (1) | BR9908706A (xx) |
| CA (1) | CA2323456A1 (xx) |
| DE (1) | DE69917237T2 (xx) |
| EE (1) | EE200000504A (xx) |
| HR (1) | HRP20000600A2 (xx) |
| HU (1) | HUP0101381A3 (xx) |
| ID (1) | ID27511A (xx) |
| IL (1) | IL138279A0 (xx) |
| IS (1) | IS5617A (xx) |
| NO (1) | NO20004517D0 (xx) |
| NZ (1) | NZ506802A (xx) |
| PL (1) | PL343419A1 (xx) |
| RU (1) | RU2199536C2 (xx) |
| SK (1) | SK13412000A3 (xx) |
| TR (1) | TR200002642T2 (xx) |
| UA (1) | UA58587C2 (xx) |
| WO (1) | WO1999046262A1 (xx) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1170827C (zh) * | 1998-03-12 | 2004-10-13 | 帝人株式会社 | 苯并呋喃基吡喃酮衍生物 |
| AU2001288432A1 (en) | 2000-09-01 | 2002-03-22 | Icos Corporation | Materials and methods to potentiate cancer treatment |
| DE10115408A1 (de) * | 2001-03-29 | 2002-10-02 | Bayer Ag | Benzofuran-Derivate |
| AU2003209990B8 (en) * | 2002-02-25 | 2008-10-30 | Kudos Pharmaceuticals Ltd | Pyranones useful as ATM inhibitors |
| DE10314610A1 (de) | 2003-04-01 | 2004-11-04 | Aventis Pharma Deutschland Gmbh | Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung |
| BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102007054497B3 (de) * | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
| FR2929276B1 (fr) * | 2008-04-01 | 2010-04-23 | Servier Lab | Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| US8785608B2 (en) | 2009-08-26 | 2014-07-22 | Sanofi | Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| DE102014214016A1 (de) | 2014-07-18 | 2015-11-05 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Leichtbaustruktur und Verfahren zur Herstellung einer Leichtbaustruktur |
| US11433047B2 (en) * | 2015-10-09 | 2022-09-06 | Neurotheryx Canada Ltd. | Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668803A (en) * | 1984-05-10 | 1987-05-26 | Atlantic Richfield Company | Benzafuran derivatives |
| DE4308451A1 (de) | 1992-09-10 | 1994-04-14 | Bayer Ag | 3-Aryl-pyron-Derivate |
| ZA938019B (en) | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| US5808062A (en) | 1993-11-19 | 1998-09-15 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
| CN1170827C (zh) * | 1998-03-12 | 2004-10-13 | 帝人株式会社 | 苯并呋喃基吡喃酮衍生物 |
-
1999
- 1999-03-12 CN CNB99805917XA patent/CN1170827C/zh not_active Expired - Fee Related
- 1999-03-12 BR BR9908706-5A patent/BR9908706A/pt not_active IP Right Cessation
- 1999-03-12 ID IDW20001761A patent/ID27511A/id unknown
- 1999-03-12 PL PL99343419A patent/PL343419A1/xx not_active Application Discontinuation
- 1999-03-12 TR TR2000/02642T patent/TR200002642T2/xx unknown
- 1999-03-12 NZ NZ506802A patent/NZ506802A/xx unknown
- 1999-03-12 EE EEP200000504A patent/EE200000504A/xx unknown
- 1999-03-12 SK SK1341-2000A patent/SK13412000A3/sk unknown
- 1999-03-12 CA CA002323456A patent/CA2323456A1/en not_active Abandoned
- 1999-03-12 IL IL13827999A patent/IL138279A0/xx unknown
- 1999-03-12 HU HU0101381A patent/HUP0101381A3/hu unknown
- 1999-03-12 KR KR1020007010037A patent/KR100595332B1/ko not_active IP Right Cessation
- 1999-03-12 WO PCT/JP1999/001225 patent/WO1999046262A1/ja not_active Application Discontinuation
- 1999-03-12 AT AT99939191T patent/ATE266659T1/de not_active IP Right Cessation
- 1999-03-12 EP EP99939191A patent/EP1063235B1/en not_active Expired - Lifetime
- 1999-03-12 DE DE69917237T patent/DE69917237T2/de not_active Expired - Fee Related
- 1999-03-12 JP JP2000535641A patent/JP3922884B2/ja not_active Expired - Fee Related
- 1999-03-12 RU RU2000125690/04A patent/RU2199536C2/ru not_active IP Right Cessation
- 1999-03-12 US US09/646,005 patent/US6589984B1/en not_active Expired - Fee Related
- 1999-03-12 AU AU32773/99A patent/AU756965B2/en not_active Ceased
- 1999-12-03 UA UA2000105676A patent/UA58587C2/uk unknown
-
2000
- 2000-09-08 IS IS5617A patent/IS5617A/is unknown
- 2000-09-11 NO NO20004517A patent/NO20004517D0/no unknown
- 2000-09-12 HR HR20000600A patent/HRP20000600A2/hr not_active Application Discontinuation
- 2000-09-12 BG BG104761A patent/BG104761A/xx unknown
-
2003
- 2003-05-12 US US10/435,746 patent/US20030186976A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IS5617A (is) | 2000-09-08 |
| TR200002642T2 (tr) | 2001-01-22 |
| HUP0101381A2 (hu) | 2002-05-29 |
| KR20010041776A (ko) | 2001-05-25 |
| AU756965B2 (en) | 2003-01-30 |
| US6589984B1 (en) | 2003-07-08 |
| EE200000504A (et) | 2002-02-15 |
| CA2323456A1 (en) | 1999-09-16 |
| DE69917237T2 (de) | 2005-05-04 |
| UA58587C2 (uk) | 2003-08-15 |
| EP1063235B1 (en) | 2004-05-12 |
| BR9908706A (pt) | 2000-11-21 |
| RU2199536C2 (ru) | 2003-02-27 |
| WO1999046262A1 (fr) | 1999-09-16 |
| JP3922884B2 (ja) | 2007-05-30 |
| CN1299359A (zh) | 2001-06-13 |
| SK13412000A3 (sk) | 2001-04-09 |
| DE69917237D1 (de) | 2004-06-17 |
| AU3277399A (en) | 1999-09-27 |
| ID27511A (id) | 2001-04-12 |
| NZ506802A (en) | 2002-11-26 |
| NO20004517L (no) | 2000-09-11 |
| CN1170827C (zh) | 2004-10-13 |
| KR100595332B1 (ko) | 2006-07-03 |
| HRP20000600A2 (en) | 2001-06-30 |
| ATE266659T1 (de) | 2004-05-15 |
| HUP0101381A3 (en) | 2002-06-28 |
| IL138279A0 (en) | 2001-10-31 |
| US20030186976A1 (en) | 2003-10-02 |
| EP1063235A1 (en) | 2000-12-27 |
| NO20004517D0 (no) | 2000-09-11 |
| PL343419A1 (en) | 2001-08-13 |
| EP1063235A4 (en) | 2003-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104761A (en) | Benzofurylpyrone derivatives | |
| PT915866E (pt) | Processo aperfeicoado para a sintese de esteres protegidos do acido (s)-3,4-di-hidroxibutirico | |
| PT1022274E (pt) | Intermediarios para a preparacao de derivados de oxazolidinodiona e de tiazolidinodiona | |
| KR940019701A (ko) | N-헤테로아릴-n'-페닐우레아 유도체, 그의 제조방법 및 용도 | |
| IE800559L (en) | Chromones. | |
| PT868182E (pt) | Processo para a producao de derivados de piperidina | |
| DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
| CA2046050A1 (en) | Bis[4-(2,6-di-alkyl)phenol]silane derivatives as antiatherosclerotic agents | |
| KR920004353A (ko) | 4,5,6,7-테트라하이드로-3-아릴-인다졸, 그의 제조방법 및 제초제로의 용도 | |
| KR880012576A (ko) | 카르복시스티렌 유도체 및 이것을 유효성분으로 함유하는 약제 | |
| KR850004959A (ko) | 아릴옥시-n-(아미노알킬)-1-피롤리딘 및 피페리딘 카복스 아미드 및 카보티오 아미드의 제조방법 | |
| DE69222076T2 (de) | Benzothiazolederivate | |
| IE892294L (en) | Cycloalkylthiazole derivatives | |
| AU2639999A (en) | Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives | |
| ATE115951T1 (de) | Glycocyamidin-derivate. | |
| DE69103985T2 (de) | N-Alkylthiazolidinderivate. | |
| AU4776399A (en) | Benflumetol derivatives, intermediates thereof and their use against parasiticalprotozoa and trematodes | |
| DE69314929D1 (de) | Benzolderivate | |
| ATE309212T1 (de) | Optisch aktive 1-phenylpyrrolidonderivate |